Susquehanna International Group, LLP Baxter International Inc Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$32.85 - $40.26 $45.7 Million - $56.1 Million	-1,392,600 Reduced 88.64%	178,500 $6.78 Million
Q2 2024 Aug 15, 2024	BUY	$32.87 - $43.55 $35.6 Million - $47.2 Million	1,084,400 Added 222.81%	1,571,100 $52.6 Million
Q1 2024 May 07, 2024	SELL	$37.88 - $43.77 $10.1 Million - $11.7 Million	-266,800 Reduced 35.41%	486,700 $20.8 Million
Q4 2023 Feb 14, 2024	BUY	$31.71 - $38.95 $9.01 Million - $11.1 Million	284,000 Added 60.49%	753,500 $29.1 Million
Q3 2023 Nov 14, 2023	SELL	$37.32 - $49.29 $17.2 Million - $22.7 Million	-460,900 Reduced 49.54%	469,500 $17.7 Million
Q2 2023 Aug 11, 2023	SELL	$39.98 - $47.68 $4.09 Million - $4.88 Million	-102,400 Reduced 9.91%	930,400 $42.4 Million
Q1 2023 May 16, 2023	BUY	$37.58 - $52.57 $21.3 Million - $29.7 Million	565,600 Added 121.06%	1,032,800 $41.9 Million
Q4 2022 Feb 14, 2023	BUY	$49.7 - $57.71 $13.4 Million - $15.5 Million	269,300 Added 136.08%	467,200 $23.8 Million
Q3 2022 Nov 14, 2022	SELL	$53.86 - $66.8 $12.2 Million - $15.1 Million	-226,300 Reduced 53.35%	197,900 $10.7 Million

1,007

450M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $14.4B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.